Trending now:  
ESC Heart Failure 2023 Highlights
Intravascular imaging-guided PCI shows better clinical outcomes than angiography-guided PCI
PORTICO NG study: Preliminary results with Navitor aortic valve are promising
Losing Sleep Over Weight Gain: Sleep Deficiency and Increased Visceral Obesity Risk
Revisiting the “Obesity-Survival Paradox” in Patients With Obesity and Heart Failure

Content for healthcare professionals only

Podcast |

Inflammation as predictor of future cardiovascular event risk

11 Apr 2023
Cardiology Update
Cardiology Update
Inflammation as predictor of future cardiovascular event risk

Both inflammation and hyperlipidemia contribute to cardiovascular disease. However in patients receiving statin therapy the relative contributions of inflammation and hyperlipidemia to future CV risk can change. As a result, this has implications on adjunctive therapy choice.

In this episode, Dr. Chadi Alraies discusses a recent study that evaluated high sensitivity CRP and LDL-C as predictors of cardiovascular event risk in patients on statin therapy.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram

Original article: Ridker PM et al. Lancet. 2023 Mar 3;S0140-6736(23)00215-5.